I think this was the deadline for them to regain compliance, and they didn't succeed.
No surprise, in that regard.
But we need to see a 10-Q/A from them for the 2nd quarter, in my opinion, accurately reflecting their (?) Tera-Immune acquisition. I think it was just a botched attempt to hide our role in the acquisition.
We've got other hooks to hang our hat on, most notably, Novavax. In addition, I'm hoping for CMML approval.